{
  "title": "Paper_471",
  "abstract": "Neurol Clin Pract Neurol Clin Pract 1965 ncp neucp NEURCLINPRACT Neurology: Clinical Practice 2163-0402 2163-0933 American Academy of Neurology PMC11165561 PMC11165561.1 11165561 11165561 38868837 10.1212/CPJ.0000000000200320 CPJ-2023-000254 1 3 13 2 213 218 7 Research Article Outcomes of Mechanical Thrombectomy for Acute Ischemic Stroke in Cancer Patients A Single-Center Experience and Meta-Analysis https://orcid.org/0000-0003-2667-4874 Elmarawany Mohamed N. MD https://orcid.org/0000-0002-3092-2159 El Malky Islam MD Winklhofer Sebastian MD, MA https://orcid.org/0000-0002-9265-8066 Katan Mira MD, MSc https://orcid.org/0009-0003-5368-571X Kar Souvik PhD Baltsavias Gerasimos MD Department of Neuroradiology (MNE, IEM, SW, MK, GB), Clinical Neuroscience Center, University Hospital Zurich, Switzerland; Department of Neurosurgery (MNE), Faculty of Medicine, Menoufia University; Department of Neurology (IEM), Faculty of Medicine, South valley University, Egypt; Department of Neurology (MK), Clinical Neuroscience Center, University Hospital Zurich, Switzerland; and International Neuroscience Institute (SK, GB), Hannover, Germany. Correspondence mohamed.nabil@med.menofia.edu.eg Funding information and disclosures are provided at the end of the article. Full disclosure form information provided by the authors is available with the full text of this article at Neurology.org/cp Submitted and externally peer reviewed. The handling editor was Associate Editor Amanda Jagolino-Cole, MD, FAAN. 10 2024 10 6 2024 14 5 464652 e200320 01 6 2023 11 3 2024 01 10 2025 01 10 2025 12 06 2024 01 10 2025 Â© 2024 American Academy of Neurology 2024 American Academy of Neurology Background and Objectives The published data about mechanical thrombectomy (MT) in cancer patients is sparse. We present our institutional experience in this clinical scenario, and a meta-analysis. Methods The baseline data, procedural data, clinical and radiological outcomes of MT were analyzed and compared among three groups of stroke patients: controls, patients with active malignancy (AM), and patients with history of malignancy (HOM). A meta-analysis of 12 studies was conducted to address the differences between controls and AM patients regarding selected outcomes. Results The 3 groups (controls, AM, HOM) showed significant differences regarding previous history of stroke or TIA (7.8% vs 10.5% vs 38.5%, p p p p p p p In the meta-analysis, the AM arm showed significantly higher mortality during hospitalization (n = 6, OR 95% CI = 3.03 [1.62, 5.64]), and at 3 months (n = 10, OR 95% CI = 4.33 [2.80, 6.68]), and significantly lower rates of 3 months functional independence (mRS = 0-2) (n = 10, OR 95% CI = 0.47 [0.32, 0.70]). No significant difference was found in sICH rates (n = 6, pooled OR 95% CI = 2.03 [0.83, 4.95]). Discussion Endovascular MT is technically successful and reasonably safe in treating AIS from LVO in active malignancy patients. However, the causes and implications of sICH require further investigation. Despite technical success, these patients experience poor clinical outcomes, and the long-term benefits of MT remain uncertain. pmc-status-qastatus 0 pmc-status-live yes pmc-status-embargo no pmc-status-released yes pmc-prop-open-access no pmc-prop-olf no pmc-prop-manuscript no pmc-prop-legally-suppressed no pmc-prop-has-pdf yes pmc-prop-has-supplement no pmc-prop-pdf-only no pmc-prop-suppress-copyright no pmc-prop-is-real-version no pmc-prop-is-scanned-article no pmc-prop-preprint no pmc-prop-in-epmc yes ",
  "metadata": {
    "Title of this paper": "Outcomes of Mechanical Thrombectomy for Acute Ischemic Stroke in Cancer Patients",
    "Journal it was published in:": "Neurology: Clinical Practice",
    "URL": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11165561/"
  }
}